Hagey Pediatric Regenerative Research Laboratory, Plastic and Reconstructive Surgery Division, Department of Surgery, Stanford University School of Medicine, Stanford, California 94305-5148, USA.
Stem Cells Dev. 2011 Mar;20(3):427-39. doi: 10.1089/scd.2010.0082. Epub 2010 Oct 17.
Human adipose-derived stromal cells (hASCs) represent a multipotent stromal cell type with a proven capacity to undergo osteogenic differentiation. Many hurdles exist, however, between current knowledge of hASC osteogenesis and their potential future use in skeletal tissue regeneration. The impact of frozen storage on hASC osteogenic differentiation, for example, has not been studied in detail. To examine the effects of frozen storage, hASCs were harvested from lipoaspirate and either maintained in standard culture conditions or frozen for 2 weeks under standard conditions (90% fetal bovine serum, 10% dimethyl sulfoxide). Next, in vitro parameters of cell morphology (surface electron microscopy [EM]), cell viability and growth (trypan blue; bromodeoxyuridine incorporation), osteogenic differentiation (alkaline phosphatase, alizarin red, and quantitative real-time (RT)-polymerase chain reaction), and adipogenic differentiation (Oil red O staining and quantitative RT-polymerase chain reaction) were performed. Finally, in vivo bone formation was assessed using a critical-sized cranial defect in athymic mice, utilizing a hydroxyapatite (HA)-poly(lactic-co-glycolic acid) scaffold for ASC delivery. Healing was assessed by serial microcomputed tomography scans and histology. Freshly derived ASCs differed significantly from freeze-thaw ASCs in all markers examined. Surface EM showed distinct differences in cellular morphology. Proliferation, and osteogenic and adipogenic differentiation were all significantly hampered by the freeze-thaw process in vitro (*P < 0.01). In vivo, near complete healing was observed among calvarial defects engrafted with fresh hASCs. This was in comparison to groups engrafted with freeze-thaw hASCs that showed little healing (*P < 0.01). Finally, recombinant insulin-like growth factor 1 or recombinant bone morphogenetic protein 4 was observed to increase or rescue in vitro osteogenic differentiation among frozen hASCs (*P < 0.01). The freezing of ASCs for storage significantly impacts their biology, both in vitro and in vivo. The ability of ASCs to successfully undergo osteogenic differentiation after freeze-thaw is substantively muted, both in vitro and in vivo. The use of recombinant proteins, however, may be used to mitigate the deleterious effects of the freeze-thaw process.
人脂肪来源的基质细胞(hASCs)是一种多能基质细胞类型,具有经过证实的成骨分化能力。然而,目前关于 hASC 成骨的知识与它们在骨骼组织再生中的潜在未来应用之间存在许多障碍。例如,冷冻保存对 hASC 成骨分化的影响尚未进行详细研究。为了研究冷冻保存的影响,从脂肪抽吸物中收获 hASCs,然后将其保持在标准培养条件下,或在标准条件下(90%胎牛血清,10%二甲基亚砜)冷冻 2 周。接下来,进行细胞形态的体外参数(表面电子显微镜[EM])、细胞活力和生长(台盼蓝;溴脱氧尿苷掺入)、成骨分化(碱性磷酸酶、茜素红和定量实时(RT)-聚合酶链反应)和脂肪生成分化(油红 O 染色和定量 RT-聚合酶链反应)。最后,通过在无胸腺小鼠的临界大小颅骨缺损中使用羟基磷灰石(HA)-聚(乳酸-共-乙醇酸)支架进行 ASC 递送,评估体内骨形成。通过连续的微计算机断层扫描和组织学评估愈合情况。新鲜衍生的 ASCs 在所有检查的标记物上均与冻融 ASCs 有明显差异。表面 EM 显示细胞形态存在明显差异。增殖以及成骨和脂肪生成分化在体外均受到冻融过程的严重阻碍(*P < 0.01)。在体内,与植入冻融 hASCs 的缺陷相比,植入新鲜 hASCs 的颅骨缺陷几乎完全愈合(*P < 0.01)。最后,观察到重组胰岛素样生长因子 1 或重组骨形态发生蛋白 4可增加或挽救冻融 hASCs 体外成骨分化(*P < 0.01)。ASCs 的冷冻储存会显著影响其生物学特性,无论是在体外还是体内。冻融后 hASC 成功进行成骨分化的能力在体外和体内均明显减弱。然而,使用重组蛋白可能会减轻冻融过程的有害影响。